New England Research & Management’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.33M | Sell |
18,461
-1,930
| -9% | -$182K | 0.52% | 62 |
|
|
2026
Q1 | $2.41M | Buy |
20,391
+344
| +2% | +$42.5K | 1.02% | 28 |
|
|
2025
Q4 | $2.52M | Sell |
20,047
-3,563
| -15% | -$465K | 1.1% | 29 |
|
|
2025
Q3 | $3.45M | Sell |
23,610
-1,178
| -5% | -$178K | 1.59% | 14 |
|
|
2025
Q2 | $3.87M | Buy |
24,788
+170
| +0.7% | +$27K | 1.84% | 10 |
|
|
2025
Q1 | $4.05M | Sell |
24,618
-325
| -1% | -$54K | 2.06% | 10 |
|
|
2024
Q4 | $4.06M | Buy |
24,943
+1,775
| +8% | +$317K | 2.07% | 7 |
|
|
2024
Q3 | $4.53M | Hold |
23,168
| – | – | 2.12% | 7 |
|
|
2024
Q2 | $4.02M | Sell |
23,168
-1,925
| -8% | -$320K | 1.93% | 7 |
|
|
2024
Q1 | $4.25M | Buy |
25,093
+1,525
| +6% | +$286K | 2.08% | 8 |
|
|
2023
Q4 | $4.65M | Buy |
23,568
+1,340
| +6% | +$237K | 2.46% | 6 |
|
|
2023
Q3 | $3.87M | Buy |
22,228
+3,975
| +22% | +$722K | 2.2% | 6 |
|
|
2023
Q2 | $3.14M | Buy |
18,253
+1,150
| +7% | +$199K | 1.82% | 13 |
|
|
2023
Q1 | $2.85M | Buy |
17,103
+200
| +1% | +$32.8K | 1.67% | 14 |
|
|
2022
Q4 | $2.48M | Sell |
16,903
-300
| -2% | -$44.4K | 1.42% | 18 |
|
|
2022
Q3 | $2.55M | Buy |
17,203
+1,200
| +7% | +$201K | 1.61% | 14 |
|
|
2022
Q2 | $2.75M | Sell |
16,003
-120
| -0.7% | -$20.8K | 1.6% | 11 |
|
|
2022
Q1 | $3.04M | Sell |
16,123
-175
| -1% | -$34.6K | 1.58% | 14 |
|
|
2021
Q4 | $3.98M | Sell |
16,298
-244
| -1% | -$53.4K | 1.92% | 8 |
|
|
2021
Q3 | $3.21M | Sell |
16,542
-26
| -0.2% | -$5.25K | 1.68% | 10 |
|
|
2021
Q2 | $3.09M | Sell |
16,568
-7
| -0% | -$1.22K | 1.6% | 11 |
|
|
2021
Q1 | $2.61M | Sell |
16,575
-71
| -0.4% | -$11.2K | 1.43% | 15 |
|
|
2020
Q4 | $2.75M | Sell |
16,646
-377
| -2% | -$61.3K | 1.7% | 12 |
|
|
2020
Q3 | $2.81M | Sell |
17,023
-175
| -1% | -$26.9K | 2.04% | 9 |
|
|
2020
Q2 | $2.36M | Sell |
17,198
-450
| -3% | -$58.8K | 1.69% | 11 |
|
|
2020
Q1 | $2.08M | Buy |
17,648
+175
| +1% | +$23K | 1.77% | 14 |
|
|
2019
Q4 | $2.31M | Sell |
17,473
-100
| -0.6% | -$12.4K | 1.55% | 11 |
|
|
2019
Q3 | $2.19M | Sell |
17,573
-500
| -3% | -$60.4K | 1.59% | 10 |
|
|
2019
Q2 | $2.05M | Hold |
18,073
| – | – | 1.39% | 13 |
|
|
2019
Q1 | $1.82M | Sell |
18,073
-450
| -2% | -$40.9K | 1.23% | 18 |
|
|
2018
Q4 | $1.58M | Sell |
18,523
-900
| -5% | -$81.1K | 1.25% | 18 |
|
|
2018
Q3 | $1.78M | Sell |
19,423
-150
| -0.8% | -$13.3K | 1.16% | 20 |
|
|
2018
Q2 | $1.67M | Sell |
19,573
-425
| -2% | -$35.9K | 1.1% | 20 |
|
|
2018
Q1 | $1.67M | Sell |
19,998
-325
| -2% | -$25.6K | 1.12% | 19 |
|
|
2017
Q4 | $1.46M | Sell |
20,323
-10,095
| -33% | -$693K | 1.05% | 27 |
|
|
2017
Q3 | $1.94M | Buy |
30,418
+900
| +3% | +$56.4K | 1.42% | 12 |
|
|
2017
Q2 | $1.84M | Buy |
29,518
+250
| +0.9% | +$14.8K | 1.36% | 13 |
|
|
2017
Q1 | $1.56M | Buy |
29,268
+10,523
| +56% | +$569K | 1.2% | 18 |
|
|
2016
Q4 | $1M | Buy |
18,745
+5,550
| +42% | +$282K | 0.79% | 36 |
|
|
2016
Q3 | $686K | Buy |
13,195
+2,350
| +22% | +$119K | 0.58% | 62 |
|
|
2016
Q2 | $515K | Sell |
10,845
-10,400
| -49% | -$491K | 0.44% | 76 |
|
|
2016
Q1 | $942K | Buy |
21,245
+425
| +2% | +$18K | 0.8% | 39 |
|
|
2015
Q4 | $998K | Sell |
20,820
-4,200
| -17% | -$190K | 0.86% | 31 |
|
|
2015
Q3 | $1.03M | Buy |
25,020
+14,420
| +136% | +$669K | 0.98% | 21 |
|
|
2015
Q2 | $511K | Buy |
10,600
+800
| +8% | +$38.2K | 0.42% | 93 |
|
|
2015
Q1 | $454K | Buy |
+9,800
| New | +$442K | 0.39% | 99 |
|
|
2014
Q4 | – | Sell |
-5,450
| Closed | -$201K | – | 191 |
|
|
2014
Q3 | $201K | Sell |
5,450
-14,075
| -72% | -$482K | 0.18% | 159 |
|
|
2014
Q2 | $630K | Buy |
19,525
+950
| +5% | +$29.1K | 0.56% | 76 |
|
|
2014
Q1 | $538K | Buy |
18,575
+2,275
| +14% | +$69.5K | 0.49% | 88 |
|
|
2013
Q4 | $533K | Buy |
+16,300
| New | +$520K | 0.51% | 76 |
|
Other funds holding ZTS
MBI
SI
MIHAS
FFM
CIM
SIM
DLA
New England Research & Management's ZTS Position: Q2 2026 in Review
New England Research & Management reduced its Zoetis (ZTS) stake by 9.5% in Q2 2026, selling an estimated $182K and leaving 18,461 shares worth $1.33M. The position accounts for 0.52% of the portfolio, ranked #62.
New England Research & Management first reported a position in ZTS in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.65M in Q4 2023. 286 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- New England Research & Management held 18,461 shares of Zoetis worth $1.33M as of Q2 2026.
- New England Research & Management sold 1,930 Zoetis shares in Q2 2026, an estimated $182K.
- Zoetis made up 0.52% of New England Research & Management's portfolio in Q2 2026, its #62 holding.
- New England Research & Management first reported a position in Zoetis in Q4 2013 and has held it in 50 quarters since.
- New England Research & Management's Zoetis position peaked at $4.65M in Q4 2023.
- 286 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.